Tamoxifen and mammographic breast densities

Cancer Epidemiology Biomarkers and Prevention

Volumn 9, Issue 9, 2000, Pages 911-915

  Brisson, J ^a   Brisson, B ^a   Cote, G ^a   Maunsell, E ^a   Berube, S ^a   Robert, J ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN;

ADULT; ARTICLE; BODY DENSITY; BREAST CANCER; CANCER PREVENTION; CANCER RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; BREAST; BREAST NEOPLASMS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MAMMOGRAPHY; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN;

EID: 0033805692     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Tamoxifen for early breast cancer: An overview of the randomised trials
2. Tamoxifen for the prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-I study
3. Prevention of breast cancer with tamoxifen: Preliminary findings from the Italian randomised trial among hysterectomised women
4. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial
5. The effect of raloxifene on risk of breast cancer in postmenopausal women: Results from the MORE randomized trial. Multiple outcomes of raloxifene evaluation
6. Breast patterns as an index of risk for developing breast cancer
7. Risk for breast cancer development determined by mammographic parenchymal pattern
8. Mammographic features of the breast and breast cancer risk
9. Mammographic signs as risk factors for breast cancer
10. Height and weight, mammographic features of breast tissue and breast cancer risk
11. Mammographic parenchymal patterns and quantitative evaluation of mammographic densities: Case-control study
12. Mammographic parenchymal features and breast cancer in the breast cancer detection demonstration project
13. Mammographic densities and risk of breast cancer
14. Quantitative classification of mammographic densities and breast cancer risk: Results from the Canadian national breast screening study
15. Mammographic features and breast cancer risk: Effects with time, age, and menopause status
16. Mammographic densities and breast cancer risk
17. Relationship between mammographic and histological risk factors for breast cancer
18. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually
19. Diet, mammographic features of breast tissue, and breast cancer risk
20. Can mammographic densities predict the effects of tamoxifen on the breast?
21. Automated analysis of mammographic densities and breast carcinoma risk
22. Antiestrogen action of raloxifene and tamoxifen: Today and tomorrow
23. Estrogens, progestogens, normal breast proliferation, and breast cancer risk
24. Endogenous hormones and breast cancer risk
25. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk
26. The detection of changes in mammographic densities
27. Effect of tamoxifen on serum insulinlike growth factor I levels in stage I breast cancer patients
28. Insulin-like growth factors
29. Immunocytochemical localization of insulin-like growth factor I receptors in primary human breast cancers
30. Circulating concentrations of insulin-like growth factor I and the risk of breast cancer
31. Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3 and mammographic density
32. Effects at two years of a low-fat, high-carbohydrate diet on radiologic features of the breast: Results from a randomized trial
33. Mammographic patterns in breast cancer chemoprevention with fenretinide (4-HPR)